04/24/2024 04:44 PM ET

Cyclacel Pharmaceuticals TNXP date announcement

Tonix Pharmaceuticals Holding now has three catalyst announcements on the calendar after revealing the date on which they will release trial results for Tonmya (TNX-102 SL) - (RELIEF/RESILIENT). Tonix Pharmaceuticals Holding plans to announce top-line [...]

04/24/2024 04:44 PM ET

Immutep Limited IMMP date announcement

Immutep Limited has an announcement scheduled for June 30, 2024 regarding their recent Phase 2b trial of Eftilagimod alpha (IMP321) and KEYTRUDA (pembrolizumab) - (TACTI-003). Our predictive system gives the drug a 33.7% chance of [...]

04/24/2024 04:44 PM ET

Innoviva INVA date announcement

Innoviva plans to announce top-line results for their NDA Filing trial of Zoliflodacin on March 31, 2025. Our calculations show a 66.4% chance that the drug makes it to the next stage.

The announcement didn’t [...]

04/24/2024 04:44 PM ET

Affimed N.V. AFMD date announcement

Affimed N.V. now has four catalyst announcements on the calendar after revealing the date on which they will release trial results for AFM24-102 and TECENTRIQ (atezolizumab). Now that the Phase 1/2 trial is completed, Affimed [...]